Cognex Corporation $CGNX Stake Trimmed by Copeland Capital Management LLC

Key Points

• Copeland Capital Management cut its Cognex stake by 33.2% in the third quarter, selling 440,558 shares and retaining 885,312 shares valued at approximately $53.7 million. Institutional investors collectively own 88.12% of the company.
• Cognex reported quarterly earnings of $0.45 per share, beating estimates by $0.03, while revenue rose 16.9% year over year to $291.26 million. The company issued fiscal 2026 EPS guidance of $1.64 to $1.68.
• The stock recently traded near $60, compared with a consensus analyst price target of $75.57 and an overall “Moderate Buy” rating. Cognex also pays a quarterly dividend of $0.085 per share, yielding about 0.6% annually.

Copeland Capital Management LLC cut its stake in Cognex Corporation (NASDAQ:CGNX - Free Report) by 33.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 885,312 shares of the scientific and technical instruments company's stock after selling 440,558 shares during the quarter. Copeland Capital Management LLC owned approximately 0.53% of Cognex worth $53,694,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the stock. Krilogy Financial LLC raised its position in shares of Cognex by 7.0% in the third quarter. Krilogy Financial LLC now owns 11,463 shares of the scientific and technical instruments company's stock worth $709,000 after acquiring an additional 746 shares during the period. NorthCrest Asset Manangement LLC boosted its stake in shares of Cognex by 59.7% during the 3rd quarter. NorthCrest Asset Manangement LLC now owns 9,812 shares of the scientific and technical instruments company's stock worth $598,000 after acquiring an additional 3,669 shares in the last quarter. Wedmont Private Capital grew its position in shares of Cognex by 7.8% during the 3rd quarter. Wedmont Private Capital now owns 5,196 shares of the scientific and technical instruments company's stock valued at $316,000 after acquiring an additional 374 shares during the period. Legacy Wealth Asset Management LLC acquired a new stake in shares of Cognex during the 3rd quarter valued at about $226,000. Finally, GAMMA Investing LLC grew its position in shares of Cognex by 47.7% during the 3rd quarter. GAMMA Investing LLC now owns 9,099 shares of the scientific and technical instruments company's stock valued at $552,000 after acquiring an additional 2,937 shares during the period. Hedge funds and other institutional investors own 88.12% of the company's stock.

Cognex Price Performance

NASDAQ:CGNX opened at $60.01 on Wednesday. The company's 50-day moving average is $61.84 and its two-hundred day moving average is $61.50. Cognex Corporation has a 1-year low of $34.60 and a 1-year high of $72.88. The firm has a market capitalization of $10.09 billion, a price-to-earnings ratio of 50.67 and a beta of 1.48.

Cognex (NASDAQ:CGNX - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.42 by $0.03. Cognex had a return on equity of 13.50% and a net margin of 16.05%. The business had revenue of $291.26 million for the quarter, compared to analyst estimates of $292.10 million. During the same quarter in the prior year, the company posted $0.25 EPS. The company's quarterly revenue was up 16.9% on a year-over-year basis. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, equities analysts anticipate that Cognex Corporation will post 1.68 earnings per share for the current fiscal year.

Cognex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 3rd. Stockholders of record on Thursday, August 20th were paid a $0.0850 dividend. The ex-dividend date of this dividend was Thursday, August 20th. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.6%. Cognex's payout ratio is presently 33.01%.

Analyst Upgrades and Downgrades

CGNX has been the topic of several research analyst reports. Truist Financial set a $74.00 price objective on Cognex and gave the company a "hold" rating in a report on Monday, October 5th. Wall Street Zen downgraded Cognex from a "buy" rating to a "hold" rating in a research note on Sunday, September 13th. Weiss Ratings raised Cognex from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, August 11th. Zacks Research lowered Cognex from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, October 6th. Finally, Citigroup reissued a "neutral" rating and issued a $74.00 price target (up from $72.00) on shares of Cognex in a research note on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $75.57.

Cognex Profile

Cognex Corporation NASDAQ: CGNX develops machine vision products and technologies that help businesses automate manufacturing, logistics and other industrial processes. Its systems enable machines to inspect, identify, measure and guide products, components and materials with limited human intervention.

The company's product portfolio includes industrial vision cameras, vision sensors, image-based barcode readers, three-dimensional vision systems and software for image processing and analysis.

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.